Risto Cel Meets Stated Pivotal Sickle Cell Endpoints

Beam said its prespecified BEACON interim analysis met the independently adjudicated endpoint of freedom from severe vaso-occlusive crises for 12 consecutive months (VF12). This is a material regulatory-stage sickle-cell signal, although the topline release…











